Magnetic Resonance Assessment of Response to Therapy: Tumor Change Measurement, Truth Data and Error Sources

Tofts, 2003 Meyer, 2009, Quantitative imaging to assess tumor response to therapy: common themes of measurement, truth data, and error sources, Transl Oncol, 2, 198, 10.1593/tlo.09208 Clarke, 2009, Quantitative imaging for evaluation of response to cancer therapy, Transl Oncol, 2, 195, 10.1593/tlo.09217 McNitt-Gray, 2009, Computed tomography assessment of response to therapy: tumor volume change measurement, truth data, and error, Transl Oncol, 2, 216, 10.1593/tlo.09226 Kinahan, 2009, PET/CT assessment of response to therapy: tumor change measurement, truth data, and error, Transl Oncol, 2, 223, 10.1593/tlo.09223 Bland, 1986, Statistical methods for assessing agreement between two methods of clinical measurement, Lancet, 1, 307, 10.1016/S0140-6736(86)90837-8 Bosca, 2009, Stability of T1 relaxation time and DCE-MRI measures. Annual Meeting of the American Association of Physicists in Medicine, Anaheim, CA, Med Phys, 36, 2705, 10.1118/1.3182265 Roberts, 2006, Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies, J Magn Reson Imaging, 23, 554, 10.1002/jmri.20529 Paldino, 2009, Repeatability of parameters derived from dynamic contrast-enhanced MR imaging Paldino, 2009, Repeatability of quantitative parameters derived from diffusion tensor imaging in patients with glioblastoma multiforme, J Magn Reson Imaging, 29, 1199, 10.1002/jmri.21732 Meyer, 2008, Parametric response mapping (PRM): voxel-based analysis of quantitative diffusion MRI changes for individualized assessment of primary breast cancer response to therapy Meyer, 2009, Parametric response mapping: a voxel-based analysis of quantitative diffusion MRI changes for individualized assessment of primary breast cancer response to therapy